Enterobacteriaceae
Investigators at Health Protection Agency Center for Infections publish new data on Enterobacteriaceae
Published in Medical Letter on the CDC and FDA, June 24th, 2007
Data detailed in "Activity of faropenem against cephalosporin-resistant Enterobacteriaceae" have been presented. According to a study from London, the United Kingdom, "There is a need for new oral agents active against extended-spectrum beta-lactamase (ESBL) producers, as these increasingly cause community-onset infections. We therefore evaluated faropenem, a penem in Phase III development, against recently collected oxyimino-cephalosporin-resistant bacteria."
"We tested 847 consecutive cephalosporin-resistant Enterobacteriaceae collected at 16 centres in South-East U.K. in 2004, 501 of them with CTX-M enzymes; we also tested reference strains and transconjugants...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Angiology
FDA Approves Ostial Pro Stent Positioning System - Angioplasty
Coronary Stents: Overview of This Common Tool to Keep Clogged Arteries Open - Cancer
Cigarette Smoke Alters DNA in Sperm, Genetic Damage Could Pass to Offspring - Colon Cancer
Exploring better ways to determine when to change the course of treatment - Colon Cancer
Taking folic acid does not reduce risk of precancerous colon tumors - Epilepsy
Experts call for urgent research into anti-epileptic drugs given to children - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
